Intra-Cellular Therapies (ITCI)
NASDAQ:ITCI
Holding ITCI?
Track your performance easily

Intra-Cellular Therapies (ITCI) Financial Statements

867 Followers

Intra-Cellular Therapies Financial Overview

Intra-Cellular Therapies's market cap is currently ―. The company's EPS TTM is $-0.862; its P/E ratio is -86.57; Intra-Cellular Therapies is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 161.39M$ 144.84M$ 133.13M$ 126.17M$ 110.13M
Gross Profit$ 161.39M$ 134.94M$ 113.48M$ 126.17M$ 110.79M
EBIT$ -16.16M$ -20.95M-$ -24.21M$ -42.65M
EBITDA$ -13.69M$ -20.82M-$ -26.27M$ -44.46M
Net Income Common Stockholders$ -16.22M$ -15.25M$ -28.58M$ -6.00M$ -42.78M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.02B$ 475.62M$ 497.94M$ 493.02M$ 514.60M
Total Assets$ 1.32B$ 747.04M$ 728.29M$ 717.66M$ 713.60M
Total Debt$ 18.29M$ 16.38M$ 16.94M$ 17.48M$ 17.99M
Net Debt$ -1.00B$ -459.25M$ -481.00M$ -475.55M$ -496.61M
Total Liabilities$ 175.89M$ 147.54M$ 136.87M$ 116.98M$ 106.51M
Stockholders Equity$ 1.14B$ 599.50M$ 591.42M$ 600.68M$ 607.09M
Cash Flow-
Free Cash Flow$ 489.00K$ -34.12M-$ -25.54M$ -36.80M
Operating Cash Flow$ 542.00K$ -34.12M$ -2.06M$ -25.27M$ -36.80M
Investing Cash Flow$ 7.77M$ 16.18M$ 47.42M$ -20.17M$ 94.75M
Financing Cash Flow$ 545.18M$ 9.99M$ 3.00M$ 2.58M$ 8.59M
Currency in USD

Intra-Cellular Therapies Earnings and Revenue History

Intra-Cellular Therapies Debt to Assets

Intra-Cellular Therapies Cash Flow

Intra-Cellular Therapies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis